These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
60 related items for PubMed ID: 454965
21. Quipazine has a biphasic effect on slow wave sleep and reduces REM sleep rebound in REM sleep deprived rats. Zak R, Radulovacki M. Brain Res Bull; 1982 Mar; 8(3):329-31. PubMed ID: 7093740 [Abstract] [Full Text] [Related]
22. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system. Dall'Olio R, Vaccheri A, Montanaro N. Pharmacol Biochem Behav; 1985 Jul; 23(1):43-8. PubMed ID: 2994121 [Abstract] [Full Text] [Related]
23. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin. Langlais PJ, Gabay S. J Neurosci Res; 1977 Jul; 3(2):135-41. PubMed ID: 563925 [Abstract] [Full Text] [Related]
24. [Antiserotonergic effect of antidepressives in quipazine-induced headshake behavior in the rat]. Fischer W, Müller M. Pharmazie; 1984 Nov; 39(11):776-7. PubMed ID: 6531385 [No Abstract] [Full Text] [Related]
26. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine. Fuller RW, Snoddy HD, Mason NR, Hemrick-Luecke SK, Clemens JA. J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711 [No Abstract] [Full Text] [Related]
27. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats. Lipham LB, Booth NH, Jernigan AD, Robbins JD, Hatch RC. Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731 [Abstract] [Full Text] [Related]
28. Aggressive behavior inhibition by serotonin and quipazine injected into the amygdala in the rat. Puciłowski O, Płaźnik A, Kostowski W. Behav Neural Biol; 1985 Jan; 43(1):58-68. PubMed ID: 4039562 [Abstract] [Full Text] [Related]
29. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat. Pfister WR, Noland V, Lowy MT, Nichols DE, Yim GK. Commun Psychopharmacol; 1978 Jan; 2(4):287-95. PubMed ID: 729354 [No Abstract] [Full Text] [Related]
30. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats. Wardley-Smith B, Hudson S, Doré CJ, Charlett A, Fletcher A, Brammer NT, Minchin MC, Wann KT. Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708 [Abstract] [Full Text] [Related]
33. Effects of malnutrition and quipazine on rat cerebral cortex ATPase activity during development. Hernández RJ. Dev Neurosci; 1980 Jul; 3(4-6):277-82. PubMed ID: 6257473 [Abstract] [Full Text] [Related]
38. Effect of quipazine on rat plasma prolactin levels. Meltzer HY, Fang VS, Paul SM, Kaluskar R. Life Sci; 1976 Oct 01; 19(7):1073-8. PubMed ID: 994712 [No Abstract] [Full Text] [Related]
39. Quipazine and induction of adrenal enzymes. Ekker M, Missala K, Sourkes TL. Biochem Pharmacol; 1984 May 15; 33(10):1687-9. PubMed ID: 6145420 [No Abstract] [Full Text] [Related]